Tumour growth inhibitory compounds and methods of their use

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP12198310.0

公开号：

EP2573176A1

申请日:

2008.04.30

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Oligonucleotides for use in the treatment of cancer wherein said treatment is an immunological therapy and comprises the administration of an antibody to the patient, and wherein said antibody is administered before the administration of an antibody. The oligonucleotide is administered topically to a mucous membrane or subcutaneously in a dose effective to up-regulate the expression of at least one of the cell surface markers CD20, CD23, CD25, CD40, CD54, CD69, CD80, and CD86, to activate NK-cells, and/or induce apoptosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/